Kick-off of the SYNERGI24-TMAO Project at Örebro University

On November 10, 2025, the SYNERGI24-TMAO project was officially launched at  Örebro University, marking the start of an ambitious interdisciplinary research initiative. The project brings together academic and clinical partners to investigate the role of trimethylamine N-oxide (TMAO) in chronic inflammatory diseases, including chronic kidney disease, cardiovascular disease, and periodontitis.

The kick-off meeting gathered researchers, collaborators, and stakeholders to align project goals, establish collaborations, and outline the strategic roadmap for the coming years